Jupiter Bioscience Profile
Key Indicators
- Authorised Capital ₹ 70.00 Cr
- Paid Up Capital ₹ 62.43 Cr
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 505.35 Cr
- Satisfied Charges ₹ 192.15 Cr
About Jupiter Bioscience
Company Details
-
Location
Bidar, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
L85110KA1985PLC006726
-
Company No.
006726
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
21 Feb 1985
-
Date of AGM
09 Aug 2010
-
Date of Balance Sheet
31 Mar 2010
-
Listing Status
Listed
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Jupiter Bioscience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkat Kalavakolanu
|
Managing Director | 10-Mar-1992 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srinivasan Mandayam
|
Director | 29-Sep-2001 | Current |
Rudolf Tanner
|
Director | 30-Sep-2005 | Current |
|
Kyoganahalli Guha
|
Director | 29-Sep-2001 | Current |
Financial Performance of Jupiter Bioscience.
Enhance accessibility to Jupiter Bioscience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jupiter Bioscience?
Unlock access to Jupiter Bioscience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sven Genetech LimitedSrinivasan Mandayam, Venkat Kalavakolanu and 1 more are mutual person
Charges (Loans)
₹505.35 Cr
₹192.15 Cr
Charges Breakdown by Lending Institutions
- Uco Bank : 76.00 Cr
- State Bank Of India : 62.50 Cr
- Ifci Limited : 60.00 Cr
- Life Insurance Corporation Of India : 50.00 Cr
- Rabo India Finance Limited : 45.00 Cr
- Others : 211.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jul 2011 | State Bank Of India | ₹15.00 Cr | Open |
| 07 Feb 2011 | State Bank Of India | ₹47.50 Cr | Open |
| 08 Jun 2010 | Department Of Biotechnology | ₹1.35 Cr | Open |
| 29 Mar 2010 | Punjab National Bank (International) Limited | ₹45.00 Cr | Open |
| 04 Feb 2010 | Ifci Limited | ₹60.00 Cr | Open |
How Many Employees Work at Jupiter Bioscience?
Unlock and access historical data on people associated with Jupiter Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jupiter Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jupiter Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
